For example, anti-bactericidal/permeability increasing protein antibodies are present in 5%–46% of patients, and anti-lactoferrin antibodies are present in 4–54% of patients with PSC; these antibodies can also be detected in patients with SLE [34, 35]. Here, BPI is linked to systemic lupus erythematosus.